Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Noa Beatrice Ciuraru"'
Autor:
Rinat Yerushalmi, Hadar Goldvaser, Aaron Sulkes, Irit Ben-Aharon, Daniel Hendler, Victoria Neiman, Noa Beatrice Ciuraru, Luisa Bonilla, Limor Amit, Alona Zer, Tal Granot, Shulamith Rizel, Salomon M Stemmer
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e107273 (2014)
PURPOSE:Four cycles of docetaxel/cyclophosphamide (DC) resulted in superior survival than doxorubicin/cyclophosphamide in the treatment of early breast cancer. The original study reported a 5% incidence of febrile neutropenia (FN) recommending prophy
Externí odkaz:
https://doaj.org/article/24047b7a98b446a99673849962c523f7
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(12)
BACKGROUND: The mouth is the most common site for measuring temperature. Oral mucositis may affect up to 40% of patients who receive chemotherapy. Thus far, mucositis has not been studied with regard to accurate thermometry. METHODS: One hundred cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::867529a363e1186a380c835c9c7e8a9f
https://pubmed.ncbi.nlm.nih.gov/18462172
https://pubmed.ncbi.nlm.nih.gov/18462172
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
Autor:
Pnina Fishman, Ofer Benjaminov, William D Kerns, Barak Singer, Salomon M. Stemmer, Motti Farbstein, Renana Petoka, Sara Bar Yehuda, Noa Beatrice Ciuraru, Gal Medalia, Sari Fishman, Shira Cohen, Zivit Harpaz, Michael H Silverman
Publikováno v:
The Oncologist. 18:25-26
Background. The A3 adenosine receptor (A3AR) is overexpressed in the tumor and in the peripheral blood mononuclear cells of patients with hepatocellular carcinoma (HCC). The orally active drug candidate CF102, an A3AR agonist, induces apoptosis of HC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7e032a8fc2d066c3849ebdbeb9fea59
https://doi.org/10.1634/theoncologist.2012-0211
https://doi.org/10.1634/theoncologist.2012-0211
Autor:
Luisa Bonilla, Daniel Hendler, Rinat Yerushalmi, Shulamith Rizel, Tal Granot, Aaron Sulkes, Irit Ben-Aharon, Noa Beatrice Ciuraru, Alona Zer, Victoria Neiman, Salomon M. Stemmer, Hadar Goldvaser, Limor Amit
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 10, p e107273 (2014)
PLoS ONE, Vol 9, Iss 10, p e107273 (2014)
Purpose Four cycles of docetaxel/cyclophosphamide (DC) resulted in superior survival than doxorubicin/cyclophosphamide in the treatment of early breast cancer. The original study reported a 5% incidence of febrile neutropenia (FN) recommending prophy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7dd00bca2ce5db68fc7a22bb02be38
https://doi.org/10.1371/journal.pone.0107273
https://doi.org/10.1371/journal.pone.0107273
Autor:
Bella Nisenbaum, B. Uziely, Larisa Ryvo, S. Rizel, Mariana Steiner, Karen Drumea, M. Leviov, Noa Beatrice Ciuraru, Salomon M. Stemmer, David B. Geffen
Publikováno v:
Journal of Geriatric Oncology. 4:S33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9d1e0f319b3c7b17ce9a37f4248914c
https://doi.org/10.1016/j.jgo.2013.09.023
https://doi.org/10.1016/j.jgo.2013.09.023
Autor:
Shulamith Rizel, Limor Amit, Rinat Yerushalmi, Aaron Sulkes, Daniel Hendler, Victoria Neiman, Luisa Bonilla, Noa Beatrice Ciuraru, Alona Zer, Salomon M. Stemmer, Tal Granot, Irit Ben-Aharon
Publikováno v:
Journal of Clinical Oncology. 30:202-202
202 Background: Four cycles of docetaxel/cyclophosohamide (DC) produced superior survival compared with doxorubicin/cyclophosphamide in the treatment of early breast cancer. The study reported 5% of febrile neutropenia (FN) events using prophylactic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4cddcf278e3f22138d9f399fe71acff3
https://doi.org/10.1200/jco.2012.30.27_suppl.202
https://doi.org/10.1200/jco.2012.30.27_suppl.202